$RNAZ
TransCode Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
TransCode Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RNAZ down today? It is at $1.16 (-10.77%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNAZ spikes, and full due diligence on RNAZ — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RNAZ 3 times in the last 30 days. Create a free account to track $RNAZ, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how RNAZ traded in the last session, Friday (last price and move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystTranscode Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filingS-8Employee share plan registration (S-8)Nov 16, 2026 · 5 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Prospectus update and an active shelf on file: the company can issue new shares
15,794,418 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Defj, Llc Beneficial Owner (10%) | Acquired (grant/award) | +13.83M 79.9% of company | added 100% | 14.13M | n/a | Aug 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.



The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how RNAZ traded in the last session, Friday (last price and move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
RNAZ last traded at $1.16, down 10.77% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The RNAZ Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNAZ 3 times in the last 30 days.
RNAZ (TransCode Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $20M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNAZ for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RNAZ discussion
Sign in to ask a question or join the discussion.